Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2153958 | Nuclear Medicine and Biology | 2013 | 7 Pages |
Abstract
The increased DNA damage induced in p53-deficient HT1080 cells suggests an early deficiency in the repair of DNA damage during the treatment period. However, the similarity in cellular sensitivity, irrespective of p53 status, suggests that reduced p53 leads to a concomitant reduction in p53-dependent cytotoxicity despite the persistence of DNA damage. The results may provide insight into how tumours that differ in p53 status respond to therapeutic radionuclides.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Amanda J. Weeks, Philip J. Blower, Daniel R. Lloyd,